Menstrual suppression among female Nigerian pilgrims during Hajj
Authors:
- Amina Mohammed-DurosinlorunAMAmina Mohammed-Durosinlorun
- Hadijat Olaide RajiHRHadijat Olaide Raji
- Nurudeen Ayoola HussainNHNurudeen Ayoola Hussain
- Saidat Adetokunbo BadmusSBSaidat Adetokunbo Badmus
- Munirdeen A IjaiyaMIMunirdeen A Ijaiya
Open Access
- 1 October 2012
- journal article
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 38 (4) , 270.1-271
Abstract
Technology to make menstruation an event of choice for many women has existed for decades and includes combined oral contraceptive pills (COCs), skipping the placebo tablets in 28-pill packs1 and, more recently, as reported in the April 2012 issue of this Journal, a flexible, extended regimen of ethinylestradiol and drospirenone.2 Other methods include taking norethisterone (Primolut N®), medroxyprogesterone acetate (Depo-Provera®), danazol, low-dose mifepristone or the use of gonadotrophin-releasing hormone analogues, endometrial ablation or hysterectomy. Breakthrough bleeding (BTB) and other side effects may limit the use of some of the aforementioned methods and some are obviously not suitable for short-term menstrual suppression.1Keywords
This publication has 4 references indexed in Scilit:
- Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled studyBMJ Sexual & Reproductive Health, 2012
- Sisters doing it for themselvesBMJ Sexual & Reproductive Health, 2009
- MENSTRUAL CYCLE, CONTRACEPTION, AND PERFORMANCEClinics in Sports Medicine, 2000
- Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.BMJ, 1977